Wealthfront Advisers LLC Invests $4.37 Million in Regeneron Pharmaceuticals, Inc. $REGN
Wealthfront Advisers LLC has acquired a new stake worth approximately $4.37 million in Regeneron Pharmaceuticals (NASDAQ:REGN). Other institutional investors like BlackRock Inc. and Norges Bank have also significantly increased their holdings in the biopharmaceutical company. Regeneron recently announced a quarterly dividend and received FDA …